Cargando…

Lestaurtinib induces DNA damage that is related to estrogen receptor activation

A number of chemicals in the environment pose a threat to human health. Recent studies indicate estradiol induces DNA damage through the activation of the estrogen receptor alpha (ERα). Given that many environmental chemical compounds act like hormones once they enter the human body, it is possible...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ooka, Masato, Yang, Shu, Zhang, Li, Kojima, Kota, Huang, Ruili, Hirota, Kouji, Takeda, Shunichi, Xia, Menghang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816669/ https://www.ncbi.nlm.nih.gov/pubmed/36619290 http://dx.doi.org/10.1016/j.crtox.2022.100102

Ejemplares similares

Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression
por: Ooka, Masato, et al.
Publicado: (2018)

Lestaurtinib inhibits Citron kinase activity and medulloblastoma growth through induction of DNA damage, apoptosis and cytokinesis failure
por: Pallavicini, Gianmarco, et al.
Publicado: (2023)

Division of labor of Y-family polymerases in translesion-DNA synthesis for distinct types of DNA damage
por: Inomata, Yuriko, et al.
Publicado: (2021)

PDIP38/PolDIP2 controls the DNA damage tolerance pathways by increasing the relative usage of translesion DNA synthesis over template switching
por: Tsuda, Masataka, et al.
Publicado: (2019)

Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells
por: Vazquez-Ortiz, Guelaguetza, et al.
Publicado: (2014)

MON-032 Identification of Estrogen-Related Receptor Alpha Inhibitors from the Tox21 10K Compound Collection
por: Lynch, Caitlin, et al.
Publicado: (2019)

Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays
por: Lynch, Caitlin, et al.
Publicado: (2019)

XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA
por: Hirota, Kouji, et al.
Publicado: (2022)

Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
por: Pinto, Nicole, et al.
Publicado: (2018)

Application of In Vitro Metabolism Activation in High-Throughput Screening
por: Ooka, Masato, et al.
Publicado: (2020)

Lestaurtinib Inhibits Histone Phosphorylation and Androgen-Dependent Gene Expression in Prostate Cancer Cells
por: Köhler, Jens, et al.
Publicado: (2012)

Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis
por: Diaz, Tania, et al.
Publicado: (2011)

NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib
por: Aubert, Léo, et al.
Publicado: (2015)

Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction
por: Cao, Yingxiao, et al.
Publicado: (2020)

Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments
por: Wu, Shuang, et al.
Publicado: (2022)

Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways
por: Sakamuru, Srilatha, et al.
Publicado: (2022)

Development of a Targeted Flip-in System in Avian DT40 Cells
por: Kobayashi, Kaori, et al.
Publicado: (2015)

Two-Dimensional Cellular and Three-Dimensional Bio-Printed Skin Models to Screen Topical-Use Compounds for Irritation Potential
por: Wei, Zhengxi, et al.
Publicado: (2020)

Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes
por: Chamberlain, Philip, et al.
Publicado: (2014)

Interference in DNA Replication Can Cause Mitotic Chromosomal Breakage Unassociated with Double-Strand Breaks
por: Fujita, Mari, et al.
Publicado: (2013)

Evolution of Pre-Existing versus Acquired Resistance to Platinum Drugs and PARP Inhibitors in BRCA-Associated Cancers
por: Yamamoto, Kimiyo N., et al.
Publicado: (2014)

A high-throughput 384-well CometChip platform reveals a role for 3-methyladenine in the cellular response to etoposide-induced DNA damage
por: Li, Jianfeng, et al.
Publicado: (2022)

Warsaw breakage syndrome DDX11 helicase acts jointly with RAD17 in the repair of bulky lesions and replication through abasic sites
por: Abe, Takuya, et al.
Publicado: (2018)

UBC13-Mediated Ubiquitin Signaling Promotes Removal of Blocking Adducts from DNA Double-Strand Breaks
por: Akagawa, Remi, et al.
Publicado: (2020)

DNA Damage Tolerance Mechanisms Revealed from the Analysis of Immunoglobulin V Gene Diversification in Avian DT40 Cells
por: Abe, Takuya, et al.
Publicado: (2018)

Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation
por: Ooka, Masato, et al.
Publicado: (2022)

The dominant role of proofreading exonuclease activity of replicative polymerase ε in cellular tolerance to cytarabine (Ara-C)
por: Tsuda, Masataka, et al.
Publicado: (2017)

The SARS-CoV-2 spike protein binds and modulates estrogen receptors
por: Solis, Oscar, et al.
Publicado: (2022)

The SARS-CoV-2 spike protein binds and modulates estrogen receptors
por: Solis, Oscar, et al.
Publicado: (2022)

Quantitative High-Throughput Identification of Drugs as Modulators of Human Constitutive Androstane Receptor
por: Lynch, Caitlin, et al.
Publicado: (2015)

Repriming by PrimPol is critical for DNA replication restart downstream of lesions and chain-terminating nucleosides
por: Kobayashi, Kaori, et al.
Publicado: (2016)

DNA polymerases ν and θ are required for efficient immunoglobulin V gene diversification in chicken
por: Kohzaki, Masaoki, et al.
Publicado: (2010)

Performance of the BG1Luc ER TA Method in a qHTS Format
por: Ceger, Patricia, et al.
Publicado: (2015)

Simultaneous Disruption of Two DNA Polymerases, Polη and Polζ, in Avian DT40 Cells Unmasks the Role of Polη in Cellular Response to Various DNA Lesions
por: Hirota, Kouji, et al.
Publicado: (2010)

Estrogen, Estrogen Receptor and Lung Cancer
por: Hsu, Li-Han, et al.
Publicado: (2017)

Chemical Incorporation of Chain-Terminating Nucleoside Analogs as 3′-Blocking DNA Damage and Their Removal by Human ERCC1-XPF Endonuclease
por: Yamamoto, Junpei, et al.
Publicado: (2016)

Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs that Modulate Farnesoid X Receptor
por: Hsu, Chia-Wen, et al.
Publicado: (2014)

Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
por: Li, Zoe, et al.
Publicado: (2023)

Roles of Estrogen, Estrogen Receptors, and Estrogen-Related Receptors in Skeletal Muscle: Regulation of Mitochondrial Function
por: Yoh, Kenta, et al.
Publicado: (2023)

Repurposing drugs as COVID-19 therapies: A toxicity evaluation
por: Ngan, Deborah K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9o3q7r006til55fu13utbmf0rk